US Defense Strategy: Investing in Biotechnology for National Security.
This Act mandates the Department of Defense (DoD) to develop a comprehensive strategy for utilizing emerging biotechnology in national security and military applications. While primarily focused on defense, this initiative is expected to boost investment in domestic commercial biotech facilities, potentially creating jobs and securing critical supply chains for essential defense products. The goal is to modernize the military by integrating advanced biotechnology solutions into equipment and operations.
Key points
Securing Supply Chains: DoD must establish a network of commercial facilities for biomanufacturing products critical for defense needs, supporting domestic industry.
International Cooperation: The strategy includes plans for coordinating research and pooling purchasing power for biotech products among NATO member countries, increasing spending efficiency.
Modernizing Defense: Military specifications will be reviewed to incorporate or substitute existing products with advanced biotechnology solutions and utilize them in war games and strategic analyses.
Introduced
Citizen Poll